Clinical Trial Update: Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients [NA]

View source ↗

Summary

A completed clinical trial update on how the OncotypeDX test influences treatment decisions in hormone receptor-positive, HER2-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OncotypeDX

Snippet

Sponsor: Genomic Health®, Inc. | Conditions: Breast Cancer | NA | Status: COMPLETED